Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men

Table 4 Correlations between adiponectin and clinical and biochemical characteristics, and cardiac dimensions, function, and myocardial metabolism

	Pooled analysis	T2DM	Controls
Age (years)	-0.070	-0.054	0.037
BMI (kg/m²)	-0.224*	-0.299*	0.495
Waist (cm)	-0.284*	-0.314*	0.153
Systolic blood pressure (mmHg)	-0.123	-0.070	0.644
Diastolic blood pressure (mmHg)	0.038	0.180	0.083
HbA1c (%)	-0.253*	-0.095	-0.616*
Log HDL-cholesterol (mmol/liter)	0.414*	0.397*	0.192
Log M-Value (mg/kg min)	0.514*	0.485*	-0.130
Rate pressure product ((beats/min)mmHg)	-0.364*	-0.270	-0.537
LV mass (g)	-0.015	-0.004	0.083
LV ejection fraction (%)	0.051	0.112	-0.338
E peak filling rate (mL/s)	0.146	0.082	0.179
Log E deceleration peak (mL/s²10^-3)	0.091	0.073	-0.035
E/A peak ratio	-0.027	-0.054	-0.018
MMRglu (nmol/mL/min)	0.288*	0.251	-0.066

Data are Pearson's r. BMI: body mass index; HbA1c: glycated hemoglobin; HDL: high-density lipoprotein; M-value: whole-body insulin sensitivity; LV: left ventricular; E/A: ratio of peak filling rates of the early filling phase and arterial contraction; MMRglu: myocardial metabolic rate of glucose uptake.
* P < 0.05.

ISSN: 1475-2840